UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

PloS one, 2020-10, Vol.15 (10), p.e0240489

2020

Volltextzugriff (PDF)

Power of the Peer and Parent: Gender Differences, Norms, and Nonmedical Prescription Opioid Use Among Adolescents in South Central Kentucky

Prevention science, 2019-07, Vol.20 (5), p.665-673

2019

Volltextzugriff (PDF)

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

BMJ open, 2020-11, Vol.10 (11), p.e038102

2020

Volltextzugriff (PDF)

What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19

Frontiers in pharmacology, 2021-01, Vol.11, p.569189

2021

Volltextzugriff (PDF)

Opioids in the United Kingdom: safety and surveillance during COVID-19

Current opinion in psychiatry, 2021-07, Vol.34 (4), p.357-362

Osborne, Vicki

2021

Volltextzugriff (PDF)

A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events

Frontiers in pharmacology, 2021-08, Vol.12, p.726141-726141

2021

Volltextzugriff (PDF)

If kids ruled the world, how would they stop the non-medical use of prescription drugs?

Journal of Health Research, 2020-08, Vol.34 (4), p.283-294

2020

Volltextzugriff (PDF)

Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion

Pharmacoepidemiology and drug safety, 2016-04, Vol.25 (4), p.476-476

Osborne, Vicki

2016

Volltextzugriff (PDF)

Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion: Impact of survival bias

Pharmacoepidemiology and drug safety, 2016-04, Vol.25 (4), p.476-476

Osborne, Vicki

2016

Volltextzugriff (PDF)

Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England

Therapeutic advances in psychopharmacology, 2020, Vol.10, p.2045125320954616-2045125320954616

2020

Volltextzugriff (PDF)

Potential impact of exposure definition when examining non‐medical use of prescription opioids among US veterans

Addiction (Abingdon, England), 2017-08, Vol.112 (8), p.1509-1510

2017

Volltextzugriff (PDF)

Potential impact of exposure definition when examining non-medical use of prescription opioids among US veterans: Letter to the Editor

Addiction (Abingdon, England), 2017-08, Vol.112 (8), p.1509-1510

2017

Volltextzugriff (PDF)

Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment

Drug safety, 2020-07, Vol.43 (7), p.645-656

2020

Volltextzugriff (PDF)

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

Drug safety, 2020-08, Vol.43 (8), p.809-821

2020

Volltextzugriff (PDF)

Examining the Utilization and Tolerability of the Non-Sedating Antihistamine Levocetirizine in England Using Prescription-Event Monitoring Data

Drug safety, 2011-12, Vol.34 (12), p.1177-1189

2011

Volltextzugriff (PDF)

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation

PloS one, 2020-10, Vol.15 (10), p.e0240489

2020

Volltextzugriff (PDF)

Non-medical opioid use in youth: Gender differences in risk factors and prevalence

Addictive behaviors, 2017-09, Vol.72, p.114-119

2017

Volltextzugriff (PDF)

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

BMJ evidence-based medicine, 2022-02, Vol.27 (1), p.1-6

2022

Volltextzugriff (PDF)

Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System

Drug safety, 2018-03, Vol.41 (3), p.313-320

2018

Volltextzugriff (PDF)

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

Drug safety, 2021-08, Vol.44 (8), p.835-841

2021

Volltextzugriff (PDF)

Prescription Opioid Use Among a Community Sample of Older and Younger Women

Journal of women's health (Larchmont, N.Y. 2002), 2022-02, Vol.31 (2), p.270-278

2022

Volltextzugriff (PDF)

Sex differences in patterns of prescription opioid non-medical use among 10–18 year olds in the US

Addictive behaviors, 2019-02, Vol.89, p.163-171

2019

Volltextzugriff (PDF)

Risk factors for prescription opioid misuse by duration of misuse

Drug and alcohol dependence, 2017-02, Vol.171, p.e156-e156

2017

Volltextzugriff (PDF)

Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry

Pharmacoepidemiology and drug safety, 2024-04, Vol.33 (4), p.e5789-n/a

2024

Volltextzugriff (PDF)

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

Drug safety, 2016-04, Vol.39 (4), p.323-333

2016

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(78)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(58)
Humans
(43)
Female
(28)
Male
(24)
Pharmacology & Pharmacy
(20)
Public, Environmental & Occupational Health
(20)
Medicine
(15)
Adolescent
(14)
Aged
(14)
Adult
(13)
Child
(13)
Medicine & Public Health
(13)
Drug Safety And Pharmacovigilance
(12)
Pharmacology/toxicology
(12)
Risk Factors
(12)
Toxicology
(12)
Covid-19
(11)
Middle Aged
(11)
Narcotics
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study

Power of the Peer and Parent: Gender Differences, Norms, and Nonmedical Prescription Opioid Use Among Adolescents in South Central Kentucky

Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

What Is the Difference Between Observed Association and Causal Association, Signals and Evidence? Examples Related to COVID-19

Opioids in the United Kingdom: safety and surveillance during COVID-19

A Systematic Review of Flurbiprofen 8.75 mg Dose and Risk of Haemorrhagic Events

If kids ruled the world, how would they stop the non-medical use of prescription drugs?

Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion

Impact of survival bias on opioid-related outcomes when using death as an exclusion criterion: Impact of survival bias

Observational assessment of safety in seroquel (OASIS): a specialist cohort event monitoring (SCEM) study in England

Potential impact of exposure definition when examining non‐medical use of prescription opioids among US veterans

Potential impact of exposure definition when examining non-medical use of prescription opioids among US veterans: Letter to the Editor

Remdesivir in Treatment of COVID-19: A Systematic Benefit–Risk Assessment

Lopinavir-Ritonavir in the Treatment of COVID-19: A Dynamic Systematic Benefit-Risk Assessment

Examining the Utilization and Tolerability of the Non-Sedating Antihistamine Levocetirizine in England Using Prescription-Event Monitoring Data

Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation

Non-medical opioid use in youth: Gender differences in risk factors and prevalence

Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?

Reported Adverse Events with Painkillers: Data Mining of the US Food and Drug Administration Adverse Events Reporting System

The Role of the Contextual Cohort to Resolve Some Challenges and Limitations of Comparisons in Pharmacoepidemiology

Prescription Opioid Use Among a Community Sample of Older and Younger Women

Sex differences in patterns of prescription opioid non-medical use among 10–18 year olds in the US

Risk factors for prescription opioid misuse by duration of misuse

Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England

Suchergebnisse filtern